Cargando…
The Promise of Specialty Pharmaceuticals: Are They Worth the Price?
BACKGROUND: Specialty pharmaceuticals have evolved beyond their status as niche drugs designed to treat rare conditions and are now poised to become the standard of care in a wide variety of common chronic illnesses. Due in part to the cost of these therapies, payers are increasingly demanding evide...
Autor principal: | Sullivan, Sean D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438149/ https://www.ncbi.nlm.nih.gov/pubmed/18507507 http://dx.doi.org/10.18553/jmcp.2008.14.S4-A.3 |
Ejemplares similares
-
Benefit Design Innovations to Manage Specialty Pharmaceuticals
por: Stern, Debbie
Publicado: (2008) -
Health Plan Approach to Operationalizing a Specialty Drug Management Program
por: Tegenu, Mesfin
Publicado: (2008) -
Looking at CER from the Pharmaceutical Industry Perspective
por: Dubois, Robert W.
Publicado: (2012) -
Asthma in the United States: Recent Trends and Current Status
por: Sullivan, Sean D.
Publicado: (2003) -
Introduction: Optimizing Outcomes Through Pharmaceutical Advances in the Treatment of Chronic Myeloid Leukemia
por: Frame, David
Publicado: (2007)